Your browser doesn't support javascript.
loading
Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients.
Sawaki, Masataka; Taira, Naruto; Uemura, Yukari; Saito, Tsuyoshi; Baba, Shinichi; Kobayashi, Kokoro; Kawashima, Hiroaki; Tsuneizumi, Michiko; Sagawa, Noriko; Bando, Hiroko; Takahashi, Masato; Yamaguchi, Miki; Takashima, Tsutomu; Nakayama, Takahiro; Kashiwaba, Masahiro; Mizuno, Toshiro; Yamamoto, Yutaka; Iwata, Hiroji; Kawahara, Takuya; Ohashi, Yasuo; Mukai, Hirofumi.
Afiliación
  • Sawaki M; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
  • Uemura Y; Biostatistics Section, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Saito T; Department of Surgery, Japanese Red Cross Saitama Hospital, Saitama, Japan.
  • Baba S; Department of Surgery, Sagara Hospital, Kagoshima, Japan.
  • Kobayashi K; Department of Medical Oncology, the Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kawashima H; Department of Surgery, Aomori City Hospital, Aomori, Japan.
  • Tsuneizumi M; Department of Breast Surgery, Shizuoka General Hospital, Shizuoka, Japan.
  • Sagawa N; Department of Breast Surgery, Kameda Medical Center, Kamogawa, Japan.
  • Bando H; Department of Breast and Endocrine Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Takahashi M; Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.
  • Yamaguchi M; Department of Breast Surgery, JCHO Kurume General Hospital, Kurume, Japan.
  • Takashima T; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Nakayama T; Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka Japan.
  • Kashiwaba M; Department of Surgery, Sagara Hospital, Kagoshima, Japan.
  • Mizuno T; Department of Medical Oncology, Mie University Hospital, Tsu, Japan.
  • Yamamoto Y; Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Kawahara T; Biostatistics Division, Clinical Research Support Center, The University of Tokyo Hospital, Tokyo, Japan.
  • Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
  • Mukai H; Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
J Clin Oncol ; 38(32): 3743-3752, 2020 11 10.
Article en En | MEDLINE | ID: mdl-32936713
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Trastuzumab Tipo de estudio: Clinical_trials Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Trastuzumab Tipo de estudio: Clinical_trials Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article